Back to search
FDAFDA · Food and drugs·Recall number D-0370-2019

Valsartan tablets USP 320 mg, 90-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-573-90.

Published January 23, 2019 · Recall initiated: December 31, 2018

Summary

FDA records drug Class II recall D-0370-2019, published January 23, 2019 and initiated December 31, 2018. Recalling firm: Aurobindo Pharma USA Inc.; Status: Ongoing; Reported quantity: 20,604 bottles; Lot: Lot # VUSD17008-A, exp. date 07/2019 Lot # VUSD17009-A, exp. date 09/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

What to do

Voluntary: Firm initiated · Press Release

Get an email if VALSARTAN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
VALSARTAN
Manufacturer
Aurobindo Pharma USA Inc.
Distributor
Product was distributed to 25 distributors and Retail Chains who may have further distributed the product throughout the United States.
Lot
Lot # VUSD17008-A, exp. date 07/2019 Lot # VUSD17009-A, exp. date 09/2019
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Valsartan tablets USP 320 mg, 90-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-573-90. recalled?

Yes. FDA published recall D-0370-2019 on January 23, 2019. Reported hazard: CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: VALSARTAN.